3-Amino-2-bromo-5-chloropyridine

Catalog No.: 
ACVAQU321
CAS No.: 
90902-83-3
Molecular Formula: 
C5H4BrClN2
Molecular Weight: 
207.46
3-Amino-2-bromo-5-chloropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$132.00In stockInquiry
500g98%$649.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Amino-2-bromo-5-chloropyridine
IUPAC Name2-bromo-5-chloropyridin-3-amine
MDL No.MFCD07368976
Molecular FormulaC5H4BrClN2
Molecular Weight207.46
SMILESNC1=CC(=CN=C1Br)Cl
InChI KeyAZOXQBMBDRLSCQ-UHFFFAOYSA-N
Synonym2-Bromo-3-Amino-5-Chloropyridine | AKOS015855685 | AM20061830 | SB78492 | 3-Pyridinamine, 2-bromo-5-chloro- | EN300-208882 | 3-AMINO-2-BROMO-5-CHLOROPYRIDINE | SY033433 | CS-0042741 | AZOXQBMBDRLSCQ-UHFFFAOYSA-N | J-508350 | 2-Bromo-5-chloro-pyridin-3-yla
CAS No.90902-83-3
PubChem CID2769640

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVAQU321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMREW639 route compound structure diagram
    ACMREW63975806-86-9In Stock
  2. Then
  3. ACVAQU321 route product structure diagram
    ACVAQU32190902-83-3In Stock
Inquiry

2. ACVAQU321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPHSO247 route compound structure diagram
    ACPHSO247137628-17-2In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACVAQU321 route product structure diagram
    ACVAQU32190902-83-3In Stock
Inquiry

3. ACVAQU321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVAQU321 route product structure diagram
    ACVAQU32190902-83-3In Stock
Inquiry

Comments (0)